Sign Up
OverviewAPI
Several biopharmaceutical companies, including Zentalis Pharmaceuticals, Taysha Gene Therapies, Kura Oncology, ORIC Pharmaceuticals, and G1 Therapeutics, have announced inducement grants through stock options and awards to attract new employees. These grants typically have a 10-year term and vest over four years, serving as incentives for employment in companies focused on developing treatments for cancer and severe monogenic diseases.

Ask a question